Purpose of the review 

Sexual and gender diverse (SGD) cancer patients possess unique identities and needs that must be considered during their cancer care. This narrative review explores the current literature on sexual and gender diversity in cancer care and survivorship, in addition to providing recommendations encouraged by the current literature.

Recent findings 

We performed a literature search for articles published in English between January 2021 and June 2022 in Medline ALL and Embase. Fifty-two studies were included in this review. The many identities encapsulated in 2SLGBTQIA+ (2 Spirited, Lesbian, Gay, Bisexual, Transgender, Queer, Intersexual, Asexual, Agender, Aromantic and all gender identities and sexual orientations that are not listed) communities each have their own unique backgrounds, needs and disparities in cancer care and survivorship. However, we also identified specific protective factors in the cancer experience of SGD patients such as reports of higher resiliency and stronger support networks. Much of the recent research features recommendations on improving cancer care by creating inclusive patient questionnaires, improving in-person and online resources, and educating healthcare providers and patient-facing staff on inclusive care.

Summary 

SGD patients have their own specific challenges during and following their cancer care. As the research continues to grow, we gain a better understanding of the needs of these patients and future steps to take to improve SGD patients’ cancer experience.

中文翻译：

---

癌症护理和生存中的性和性别多样性

审查的目的 

性和性别多样化 (SGD) 癌症患者具有独特的身份和需求，在他们的癌症治疗过程中必须考虑到这一点。这篇叙述性综述探讨了当前关于癌症护理和生存中的性和性别多样性的文献，此外还提供了受当前文献鼓励的建议。

最近的发现 

我们对 2021 年 1 月至 2022 年 6 月期间在 Medline ALL 和 Embase 中以英文发表的文章进行了文献检索。本综述纳入了 52 项研究。2SLGBTQIA+（2 个活泼的、女同性恋、男同性恋、双性恋、跨性别者、酷儿、双性恋者、无性恋者、无性别者、自恋者以及所有未列出的性别认同和性取向）社区中包含的许多身份，每个人都有自己独特的背景、需求和差异在癌症护理和生存方面。然而，我们还确定了 SGD 患者癌症经历中的特定保护因素，例如更高弹性和更强支持网络的报告。最近的大部分研究都提出了通过创建包容性患者问卷、改善面对面和在线资源来改善癌症护理的建议，

概括 

SGD 患者在癌症治疗期间和之后都有自己的特定挑战。随着研究的不断发展，我们对这些患者的需求有了更好的了解，并了解了未来为改善 SGD 患者的癌症体验而采取的措施。